The Ohio pharmacy board has rescinded a rule prohibiting the prescription of a malaria drug for use by patients with COVID-19.
At issue is the prescribing of the drug hydroxychloroquine, whose effectiveness for the coronavirus has been widely questioned. On Wednesday, the pharmacy board banned its use as a coronavirus treatment, noting that the Food and Drug Administration previously revoked the emergency use of the drug.
The FDA “made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery,” the state pharmacy board said.
But on Thursday, FDA Commissioner Dr. Steven Hahn said on NBC's “Today” show that the drug's use should be between doctor and patient. Gov. Mike DeWine said he agreed with that assessment.
“The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts,” DeWine said.
Shortly after the governor’s statement, officials with the Ohio State Medical Association said the rule was rescinded "as a result of the feedback received by the medical and patient community and at the request of Governor DeWine."
On Tuesday, President Donald Trump once again promoted the use of the drug when he retweeted a viral video of a group of doctors promoting the use of the drug. Both Twitter and Facebook have removed the content in efforts to keep the sites free of harmful misinformation about the virus.
Ohio is currently under a statewide mask order. Local efforts to clamp down further have had mixed results.
In Columbus, a judge on Tuesday quickly shot down a city order closing bars and restaurants at 10 p.m., setting a hearing in two weeks where evidence can be presented for and against such a shutdown.
Columbus Mayor Andrew Ginther and City Attorney Zach Klein say the order is needed because compliance with social distancing worsens late at night.
The Associated Press contributed to this report.